Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
2
×
astrazeneca
biotech
boston blog main
boulder/denver blog main
boulder/denver top stories
cancer
covid-19
deals
detroit blog main
detroit top stories
europe blog main
europe top stories
gilead sciences
indiana blog main
indiana top stories
life sciences
national
national blog main
2
×
national top stories
new york blog main
new york top stories
novartis
raleigh-durham blog main
2
×
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
takeda pharmaceutical
texas blog main
texas top stories
2
×
unity biotechnology
wisconsin blog main
wisconsin top stories
akouos
allergan
What
acquisitions
bio
ceo
daniel
2
×
gilead
o’day
roundup
sciences
announced
biggest
build
buy
collabs
company’s
covid
deal
debut
drug
dyne’s
gilead’s
help
introduce
ipo
medicines
microbiome
month
moves
openly
pipeline
plans
scores
seagen
spoken
transformative
way
week
years
Language
unset
2
×
Current search:
abbvie
×
unset
×
" national blog main "
×
" texas top stories "
×
" raleigh-durham blog main "
×
daniel
×
@xconomy.com
4 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More